| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MRSN (MRSN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. MRSN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| VP | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | Mandelia Ashish | VP, Chief Accounting Officer | Sale+OE | 1,791 | $0.63 | $1,128.33 | -3.3% | |
| Jan 15, 2025 | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Sale+OE | 1,794 | $0.63 | $1,130.22 | -0.7% | |
| Jan 15, 2025 | Deschuytner Brian | SVP, COO &CFO | Sale+OE | 2,331 | $0.63 | $1,468.53 | -2.1% | |
| Jan 15, 2025 | Carvajal Alejandra | SVP, Chief Legal Officer | Sale+OE | 952 | $0.63 | $599.76 | -1.3% | |
| Jan 14, 2025 | Bala Mohan | SVP, Chief Development Officer | Sale+OE | 3,253 | $0.66 | $2,146.98 | -5.1% | |
| Jan 14, 2025 | Protopapas Anna | Director | Sale+OE | 11,534 | $0.66 | $7,612.44 | -7.4% | |
| Jan 14, 2025 | Mandelia Ashish | VP, Chief Accounting Officer | Sale+OE | 1,007 | $0.66 | $664.62 | -2.0% | |
| Jan 14, 2025 | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Sale+OE | 3,483 | $0.66 | $2,298.78 | -1.4% | |
| Jan 14, 2025 | Deschuytner Brian | SVP, COO &CFO | Sale+OE | 3,713 | $0.66 | $2,450.58 | -3.4% | |
| Jan 14, 2025 | Carvajal Alejandra | SVP, Chief Legal Officer | Sale+OE | 3,330 | $0.66 | $2,197.80 | -4.6% |